Who oversees innovative practice? Is there a structure that meets the monitoring needs of new techniques?

J Am Coll Surg

Section of Hepato-Pancreato-Biliary Surgery, Department of Surgery, St Louis, MO 63110, USA.

Published: June 2003

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1072-7515(03)00112-1DOI Listing

Publication Analysis

Top Keywords

oversees innovative
4
innovative practice?
4
practice? structure
4
structure meets
4
meets monitoring
4
monitoring techniques?
4
oversees
1
practice?
1
structure
1
meets
1

Similar Publications

The Role and Future of Artificial Intelligence in Robotic Image-Guided Interventions.

Tech Vasc Interv Radiol

December 2024

Department of Interventional Radiology, MedStar Georgetown University Hospital, Washington, DC. Electronic address:

Artificial intelligence and robotics are transforming interventional radiology, driven by advancements in computer vision, robotics and procedural automation. Historically focused on diagnostics, AI now also enhances procedural capabilities in IR, enabling future robotic systems to handle complex tasks such as catheter manipulation or needle placement with increasing precision and reliability. Early robotic systems in IR demonstrated improved accuracy in both vascular and percutaneous interventions, though none were equipped with automatic decision-making.

View Article and Find Full Text PDF

Although the integration of artificial intelligence (AI) into medicine and healthcare holds transformative potential, significant challenges must be necessarily addressed. This technological innovation requires a commitment to ethical principles. Key issues concern autonomy, reliability, and bias.

View Article and Find Full Text PDF

Rapid growth in bio-logging-the use of animal-borne electronic tags to document the movements, behaviour, physiology and environments of wildlife-offers opportunities to mitigate biodiversity threats and expand digital natural history archives. Here we present a vision to achieve such benefits by accounting for the heterogeneity inherent to bio-logging data and the concerns of those who collect and use them. First, we can enable data integration through standard vocabularies, transfer protocols and aggregation protocols, and drive their wide adoption.

View Article and Find Full Text PDF

US regulatory compliance for medical combination products: an overview.

Front Med Technol

December 2024

Advance Academic Programs, Krieger School of Arts and Sciences, Johns Hopkins University, Washington, DC, United States.

This article provides a high-level overview of US regulatory review and approval processes for the growing field of medical combination products (CPs; those merging drugs with devices and/or biological products). US law defines drugs, medical devices, and CPs in specific ways, and the components of a CP are still subject to their respective regulations while combined. The Food and Drug Administration's Office of Combination Products (OCP) oversees the review and classification of CPs, which is based on their primary mode of action.

View Article and Find Full Text PDF

Introduction: Trachoma is caused by the bacterium (). The WHO recommends the SAFE strategy for trachoma elimination: Surgery for trichiasis, Antibiotics, Facial cleanliness and Environmental improvement. Multiple rounds of SAFE implementation have proven insufficient to eliminate trachoma in Ethiopia, where over 50% of the global trachoma burden remains.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!